510(k) · Cleared
ClearedVianox Delivery System, Model I
Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly
Pulmonox Medical, Inc. · MRP Analyzer, Nitric Oxide
Cleared on Aug 14, 2003 after a 338-day review. The FDA summary names its predicate without a number. 5 of the 26 devices in its family, counting itself, have a Class I recall. 25 later devices descend from it.
- Decided
- Aug 14, 2003
- Review
- 338 days
- Class
- Class II
- Product code
- MRP
- Recalls
- None
- Predicates
- 0
25 later devices descend from it, 1 citing it directly. 5 of the 26 devices in this family, counting this one, have a Class I recall.
- This deviceK023014 Vianox Delivery System, Model IPulmonox Medical, Inc. · 2003
- Descendant · cites it directly · 24 of its ownK061901 Ino Therapeutics Inomax DS (Delivery System), Model 10003Ino Therapeutics · 2006 · Recalled
- Descendant · 2 generations on · 16 of its ownK092545 Inomax DS (Delivery System), Model 10003Ino Therapeutics, LLC · 2010
- Descendant · 2 generations on · 15 of its ownK070867 Inomax DS (Delivery System), Model 10003Ino Therapeutics, LLC · 2007
- Descendant · 2 generations on · 14 of its ownK071516 Inomax DSIno Therapeutics, LLC · 2007
- Descendant · 2 generations on · 11 of its ownK093922 Inomax DSIno Therapeutics · 2010 · Recalled
Showing 5 of 25 descendants. See all descendants
Descendants cleared per year
Class I recalls in this family
Most influential descendants
Showing 5 of 25 · See all- K061901Ino Therapeutics Inomax DS (Delivery System), Model 10003Ino Therapeutics · 2006 · cites it directly24descendants
- K092545Inomax DS (Delivery System), Model 10003Ino Therapeutics, LLC · 2010 · 2 generations on16descendants
- K070867Inomax DS (Delivery System), Model 10003Ino Therapeutics, LLC · 2007 · 2 generations on15descendants
- K071516Inomax DSIno Therapeutics, LLC · 2007 · 2 generations on14descendants
- K093922Inomax DSIno Therapeutics · 2010 · 2 generations on11descendants
View FIG. 1 as a table
Line of descent and top descendants
| Generation | Number | Device | Applicant | Decided | Recalls |
|---|---|---|---|---|---|
| 0 (this device) | K023014 | Vianox Delivery System, Model I | Pulmonox Medical, Inc. | 2003 | — |
| +1 | K061901 | Ino Therapeutics Inomax DS (Delivery System), Model 10003 | Ino Therapeutics | 2006 | 3 |
| +2 | K092545 | Inomax DS (Delivery System), Model 10003 | Ino Therapeutics, LLC | 2010 | — |
| +2 | K070867 | Inomax DS (Delivery System), Model 10003 | Ino Therapeutics, LLC | 2007 | — |
| +2 | K071516 | Inomax DS | Ino Therapeutics, LLC | 2007 | — |
| +2 | K093922 | Inomax DS | Ino Therapeutics | 2010 | 1 |
Descendants by year cleared
| Year cleared | Devices | With a Class I recall |
|---|---|---|
| 2006 | 1 | 0 |
| 2007 | 2 | 0 |
| 2008 | 2 | 0 |
| 2009 | 1 | 0 |
| 2010 | 2 | 0 |
| 2011 | 2 | 0 |
| 2012 | 3 | 0 |
| 2013 | 2 | 0 |
| 2015 | 1 | 0 |
| 2018 | 1 | 1 |
| 2020 | 2 | 1 |
| 2022 | 1 | 1 |
| 2023 | 3 | 1 |
| 2024 | 1 | 1 |
| 2025 | 1 | 0 |
Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.
5 devices in this family have a Class I recall. A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.
- Candidate predicates for a device like this, rankedin the report
- Recall history across each candidate’s familyin the report
What was it cleared against? (1)
Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.
| Type | Number | Device | Decided |
|---|---|---|---|
| * | — | INOvent Delivery System Named without a submission number |
What descends from it? (25)
See all 251 later device cites it directly; ranked here by how many devices descend from each in turn.
| Number | Device | Decided | Descendants |
|---|---|---|---|
| K061901 | Ino Therapeutics Inomax DS (Delivery System), Model 10003 | 2006 | 24 |
Has anything in its family been recalled? (5 Class I)
No FDA recall names this device.
Relatives with a Class I recall
Class I is FDA’s most serious recall class. A recall in the family tree is context for this device, not evidence about it.
- K171696NOxBOXi Nitric Oxide Delivery SystemPraxair Distribution, Inc. · 2018 · 3 generations on · ◆ in the 2018 descendants bar of FIG. 13 Class I recalls
- K220898NOxBOXi Nitric Oxide Delivery SystemLinde Gas & Equipment, Inc. · 2022 · 4 generations on · ◆ in the 2022 descendants bar of FIG. 12 Class I recalls
- K201339The NOxBOXi Nitric Oxide Delivery SystemPraxair, Inc. · 2020 · 4 generations on · ◆ in the 2020 descendants bar of FIG. 12 Class I recalls
- K231823NOxBOXi Nitric Oxide Delivery SystemLinde Gas & Equipment, Inc. · 2023 · 5 generations on · ◆ in the 2023 descendants bar of FIG. 12 Class I recalls
- K233251NOxBOXi Nitric Oxide Delivery SystemLinde Gas & Equipment, Inc. · 2024 · 6 generations on · ◆ in the 2024 descendants bar of FIG. 12 Class I recalls
What does this lineage say?
- Of its descendants, K061901 (Ino Therapeutics, 2006) has gone furthest, with 24 descendants of its own.
How does its category compare?
All MRP devicesMRP Analyzer, Nitric Oxide: FDA decisions, review times, recalls and adverse event reports over 20 years.
FDA decisions per year · MRP
FDA has decided no MRP device since 2007.
Median 510(k) review, days · MRP
Too few MRP 510(k)s in any year since 2007 to give a median.
Recalls per year · MRP
No recall names MRP since 2007.
Adverse event reports per year · MRP
2in 2024
MAUDE reports naming product code MRP, not matched to any one device; reports are not rates.
View these four charts as a table
| Year | Decisions | Median 510(k) review, days | Recalls (Class I) | MAUDE reports |
|---|---|---|---|---|
| 2007 | 0 | — | 0 | 0 |
| 2008 | 0 | — | 0 | 1 |
| 2009 | 0 | — | 0 | 0 |
| 2010 | 0 | — | 0 | 1 |
| 2011 | 0 | — | 0 | 8 |
| 2012 | 0 | — | 0 | 4 |
| 2013 | 0 | — | 0 | 7 |
| 2014 | 0 | — | 0 | 11 |
| 2015 | 0 | — | 0 | 0 |
| 2016 | 0 | — | 0 | 0 |
| 2017 | 0 | — | 0 | 0 |
| 2018 | 0 | — | 0 | 0 |
| 2019 | 0 | — | 0 | 0 |
| 2020 | 0 | — | 0 | 0 |
| 2021 | 0 | — | 0 | 0 |
| 2022 | 0 | — | 0 | 0 |
| 2023 | 0 | — | 0 | 0 |
| 2024 | 0 | — | 0 | 2 |
| 2025 | 0 | — | 0 | 0 |
| 2026 | 0 | — | 0 | — |
What is it indicated for?
The ViaNOx Delivery System is a nitric oxide administration device intended to add nitric oxide to gases that are to be breathed by a patient, and to be used in conjunction with a ventilator or other breathing system. The ViaNOx includes a nitric oxide, nitrogen dioxide, and oxygen monitor intended to monitor the concentration of these gases in respiratory gas mixtures during administration of nitric oxide.
Indications for use as stated in the FDA summary.
https://510kreport.com/device/K023014 · printed Nov 6, 2026
Cite this page
510(k) Report. “K023014: Vianox Delivery System, Model I.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K023014
Report an extraction error
Are you the manufacturer?
Record history
- FDA decision record loaded May 2, 2026
- Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
- Lineage and recalls computed Nov 3, 2026
- Page last updated Nov 3, 2026